StockNews.com assumed coverage on shares of Merrimack Pharmaceuticals (NASDAQ:MACK – Get Rating) in a note issued to investors on Monday. The firm set a “sell” rating on the biopharmaceutical company’s stock. Shares of MACK opened at $4.95 on Monday. The firm’s 50-day moving average price is $5.71 and its 200-day moving average price is $5.30. […]
StockNews.com started coverage on shares of Merrimack Pharmaceuticals (NASDAQ:MACK – Get Rating) in a report released on Saturday. The brokerage set a “sell” rating on the biopharmaceutical company’s stock. NASDAQ:MACK opened at $5.25 on Friday. The company has a market capitalization of $70.40 million, a price-to-earnings ratio of -37.50 and a beta of 1.68. Merrimack […]
StockNews.com began coverage on shares of Merrimack Pharmaceuticals (NASDAQ:MACK – Get Rating) in a report issued on Wednesday. The brokerage set a “sell” rating on the biopharmaceutical company’s stock. Shares of MACK opened at $5.58 on Wednesday. The stock’s 50-day moving average is $6.24 and its two-hundred day moving average is $5.15. The stock has […]
StockNews.com assumed coverage on shares of Merrimack Pharmaceuticals (NASDAQ:MACK – Get Rating) in a report issued on Monday. The brokerage set a “sell” rating on the biopharmaceutical company’s stock. Shares of MACK stock opened at $6.24 on Monday. Merrimack Pharmaceuticals has a 12 month low of $3.66 and a 12 month high of $7.97. The […]
StockNews.com began coverage on shares of Merrimack Pharmaceuticals (NASDAQ:MACK – Get Rating) in a research report released on Sunday. The firm issued a sell rating on the biopharmaceutical company’s stock. Shares of NASDAQ MACK opened at $6.39 on Friday. The stock has a market capitalization of $85.69 million, a P/E ratio of -35.50 and a […]